S. Parikh Pharma Private Limited - Company Profile

It is a pharma private limited company based in Mumbai, Maharashtra, India, established in 2008.
2008 Mumbai, Maharashtra, India Active
Last Updated:
Access Report
About S. Parikh Pharma Private Limited

S. Parikh Pharma Private Limited, a active private limited company, was established on 10 October 2008 in Mumbai, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U74999MH2008PTC187415. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹3.00 Cr and a paid-up capital of ₹4.53 M.

It upholds a compliant status. Employing 77 professional, Its leadership includes Bhaumik Rohit Shah (Director), Nikesh Shailesh Parekh (Director), Nemish Shah Rajesh (Director). Past directors included Bhaumik Rohit Shah, Pritesh Rajeshkumar Shah, Nikesh Shailesh Parekh. It holds ₹11.60 Cr open charges and ₹10.10 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 1St Floor, Gala No. 6, Hitex Industrial Estate, Behind Petrol Pump, S.V. Road, Dahisar E, Ast,, Mumbai, Maharashtra, 400068.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U74999MH2008PTC187415

  • Registration Number

    187415

  • Incorporation Date

    10 October 2008

  • Authorized Capital

    ₹3.00 Cr

  • Paid-Up Capital

    ₹4.53 M

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 3.00 Cr
  • Paid Up Capital ₹ 4.53 M
  • Company Age 17 Year, 7 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 11.60 Cr
  • Satisfied Charges ₹ 10.10 Cr
  • Revenue Growth **** -2.01%
  • Profit Growth **** -8.93%
  • Ebitda **** -77.80%
  • Net Worth 17.56%
  • Total Assets **** 8.49%
Company report

S. Parikh Pharma Private Limited

Company Report FY 2026-2027

Comprehensive Company Insights

Explore comprehensive insights into S. Parikh Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at S. Parikh Pharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Bhaumik Rohit Shah Director 16 Apr 2009 Current
Nikesh Shailesh Parekh Director 16 Mar 2018 Current
Nemish Shah Rajesh Director 05 Sep 2011 Current
Ashwin Mehta Shantilal Director 16 Apr 2009 Current
Ankit Hemant Shah Director 18 Feb 2016 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 30 Sep 2009 Past
Pramod Abcsdd Additional Director 27 May 2009 Past
Pramod Abcsdd Additional Director 30 Sep 2018 Past
Pramod Abcsdd Director 22 Apr 2014 Past
Pramod Abcsdd Additional Director 30 Sep 2011 Past
Pramod Abcsdd Director 16 Apr 2009 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of S. Parikh Pharma.

S. Parikh Pharma Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 2.01% decrease. The company also saw a slight decrease in profitability, with a 8.93% decrease in profit. The company's net worth Soared by an impressive increase of 17.56%.

S. Parikh Pharma revenue growth over time
S. Parikh Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -2.01%
*******
*******
*******
*******
Revenue from Operations
*******
 -2.65%
*******
*******
*******
*******
Total Assets
*******
 8.49%
*******
*******
*******
*******
Profit or Loss
*******
 -8.93%
*******
*******
*******
*******
Net Worth
*******
 17.56%
*******
*******
*******
*******
EBITDA
*******
 -77.80%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of S. Parikh Pharma?

In 2023, S. Parikh Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹116,000,000.00

Satisfied Charges

₹101,000,000.00

Charges Breakdown by Lending Institutions
  • The Hongkong And Shanghai Banking Corporation Limited : 11.60 Cr
Latest Charge Details
Date Lender Amount Status
16 Dec 2016 The Hongkong And Shanghai Banking Corporation Limited ₹10.00 Cr Open
16 Dec 2016 The Hongkong And Shanghai Banking Corporation Limited ₹1.60 Cr Open
16 Jun 2012 Vasai Vikas Sahakari Bank Ltd ₹4.50 Cr Satisfied
24 Mar 2011 The Royal Bank Of Scotland N.V. ₹2.60 Cr Satisfied
08 Nov 2009 Abn Amro Bank N.V. ₹3.00 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at S. Parikh Pharma?

S. Parikh Pharma has a workforce of 77 employees as of Mar 29, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of S. Parikh Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped S. Parikh Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on S. Parikh Pharma
Recent Activity within the Organization
  • Annual General Meeting

    S. Parikh Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    S. Parikh Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was recorded as a recent event.

  • Charges

    A charge with The Hongkong And Shanghai Banking Corporation Limited of Rs. 10.00 Cr registered on 16 Dec 2016 with Charge ID 100075840 was modified on 22 May 2018. was recorded as a recent event.

  • Director Appointment

    Progress on Nikesh Shailesh Parekh was appointed as a Director was appointed as a Director on 16 Mar 2018 & has been associated with this company since 8 years 2 months . was documented.

  • Charges

    The activity A charge registered on 16 Jun 2012 via Charge ID 10368623 with Vasai Vikas Sahakari Bank Ltd was fully satisfied on 29 Mar 2017. was completed.

  • Charges

    A charge with The Hongkong And Shanghai Banking Corporation Limited amounted to Rs. 1.60 Cr with Charge ID 100075841 was registered on 16 Dec 2016. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of S. Parikh Pharma Private Limited?

The CIN of S. Parikh Pharma Private Limited is U74999MH2008PTC187415.

Where is S. Parikh Pharma Private Limited headquartered?

S. Parikh Pharma Private Limited is headquartered at 1St Floor, Gala No. 6, Hitex Industrial Estate, Behind Petrol Pump, S.V. Road, Dahisar E, Ast,, Mumbai, Maharashtra, 400068.

When was S. Parikh Pharma Private Limited incorporated?

S. Parikh Pharma Private Limited was incorporated on 10 October 2008.

Who are the current directors of S. Parikh Pharma Private Limited?

The current directors of S. Parikh Pharma Private Limited are

What is the primary industry of S. Parikh Pharma Private Limited?

The primary industry of S. Parikh Pharma Private Limited is Trade.

Is S. Parikh Pharma Private Limited a listed company?

S. Parikh Pharma Private Limited is unlisted.

What is the capital structure of S. Parikh Pharma Private Limited?

The authorized capital of S. Parikh Pharma Private Limited is ₹3.00 Cr, and the paid-up capital is ₹4.53 M.

What is the compliance status of S. Parikh Pharma Private Limited?

The compliance status of S. Parikh Pharma Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available